JP2022541192A5 - - Google Patents
Info
- Publication number
- JP2022541192A5 JP2022541192A5 JP2022502425A JP2022502425A JP2022541192A5 JP 2022541192 A5 JP2022541192 A5 JP 2022541192A5 JP 2022502425 A JP2022502425 A JP 2022502425A JP 2022502425 A JP2022502425 A JP 2022502425A JP 2022541192 A5 JP2022541192 A5 JP 2022541192A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- amino acid
- acid sequence
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1910138.5 | 2019-07-15 | ||
| GBGB1910138.5A GB201910138D0 (en) | 2019-07-15 | 2019-07-15 | Anti-pd-l1 antibodies |
| PCT/EP2020/070065 WO2021009267A1 (en) | 2019-07-15 | 2020-07-15 | Anti-pd-l1 antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022541192A JP2022541192A (ja) | 2022-09-22 |
| JP2022541192A5 true JP2022541192A5 (https=) | 2023-07-18 |
| JP7653408B2 JP7653408B2 (ja) | 2025-03-28 |
Family
ID=67700332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022502425A Active JP7653408B2 (ja) | 2019-07-15 | 2020-07-15 | 抗ｐｄ－ｌ１抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220356255A1 (https=) |
| EP (1) | EP3999113A1 (https=) |
| JP (1) | JP7653408B2 (https=) |
| KR (1) | KR20220057526A (https=) |
| CN (1) | CN114829400B (https=) |
| CA (1) | CA3143957A1 (https=) |
| GB (1) | GB201910138D0 (https=) |
| WO (1) | WO2021009267A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112023016706A2 (pt) * | 2021-02-19 | 2023-10-31 | Seoul Nat Univ R&Db Foundation | Anticorpo ou um fragmento de ligação ao antígeno do mesmo, molécula de ácido nucleico, métodos para produzir um anticorpo ou um fragmento de ligação ao antígeno do mesmo e para detectar agrupamento de diferenciação 47 ou determinar uma quantidade de agrupamento de diferenciação 47 em uma amostra, e, uso do anticorpo ou de um fragmento de ligação ao antígeno do mesmo |
| CN116917322A (zh) * | 2021-02-19 | 2023-10-20 | 沙裴隆有限公司 | 针对pd-l1及cd47的双特异性单域抗体及其用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2156149T3 (es) | 1992-12-04 | 2001-06-16 | Medical Res Council | Proteinas de union multivalente y multiespecificas, su fabricacion y su uso. |
| AU2003281200A1 (en) * | 2002-07-03 | 2004-01-23 | Tasuku Honjo | Immunopotentiating compositions |
| PT1907424E (pt) * | 2005-07-01 | 2015-10-09 | Squibb & Sons Llc | Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1) |
| PL2504364T3 (pl) | 2009-11-24 | 2017-12-29 | Medimmune Limited | Ukierunkowane środki wiążące przeciwko B7-H1 |
| KR101764096B1 (ko) * | 2011-11-28 | 2017-08-02 | 메르크 파텐트 게엠베하 | 항-ｐｄ-ｌ1 항체 및 그의 용도 |
| HK1203971A1 (en) | 2012-05-15 | 2015-11-06 | Bristol-Myers Squibb Company | Cancer immunotherapy by disrupting pd-1/pd-l1 signaling |
| BR112015007672A2 (pt) * | 2012-10-04 | 2017-08-08 | Dana Farber Cancer Inst Inc | anticorpos anti-pd-l1 monoclonais humanos e métodos de uso |
| US9209965B2 (en) | 2014-01-14 | 2015-12-08 | Microsemi Semiconductor Ulc | Network interface with clock recovery module on line card |
| TWI680138B (zh) * | 2014-01-23 | 2019-12-21 | 美商再生元醫藥公司 | 抗ｐｄ-ｌ１之人類抗體 |
| CN105777906B (zh) * | 2014-12-19 | 2019-04-23 | 苏州丁孚靶点生物技术有限公司 | 抗pd-l1全人抗体及其应用 |
| CN106939047B (zh) * | 2016-01-04 | 2021-08-31 | 江苏怀瑜药业有限公司 | 一种pd-l1抗体及其制备方法 |
| CA3007135A1 (en) * | 2016-03-23 | 2017-09-28 | Mabspace Biosciences (Suzhou) Co., Ltd | Novel anti-pd-l1 antibodies |
| CN108948193B (zh) * | 2017-05-18 | 2022-12-09 | 上海健信生物医药科技有限公司 | 针对tim-3的抗体分子,抗原结合片段及其医药用途 |
-
2019
- 2019-07-15 GB GBGB1910138.5A patent/GB201910138D0/en not_active Ceased
- 2019-07-15 US US17/627,517 patent/US20220356255A1/en active Pending
-
2020
- 2020-07-15 WO PCT/EP2020/070065 patent/WO2021009267A1/en not_active Ceased
- 2020-07-15 JP JP2022502425A patent/JP7653408B2/ja active Active
- 2020-07-15 CN CN202080064795.6A patent/CN114829400B/zh active Active
- 2020-07-15 EP EP20742695.8A patent/EP3999113A1/en active Pending
- 2020-07-15 CA CA3143957A patent/CA3143957A1/en active Pending
- 2020-07-15 KR KR1020227005068A patent/KR20220057526A/ko active Pending